The use of site-specific recombination and cassette exchange technologies for monoclonal antibody production in Chinese Hamster ovary cells: retrospective analysis and future directions

References

• Walsh G. Biopharmaceutical benchmarks 2014. Nat Biotechnol. 2014;32(10):992–1000.
   PubMed Web of Science ®Google Scholar
• Peters RC. Solving pharma’s post-Brexit puzzle. Pharm Technol. 2017;41(1).
   Google Scholar
• Osborne R. Fresh from the biotech pipeline—2012. Nat Biotechnol. 2013;31(2):100–103.
   Google Scholar
• Walsh G. Biopharmaceutical benchmarks 2018. Nat Biotechnol. 2018;36(12):1136–1145.
   PubMed Web of Science ®Google Scholar
• Kozlowski S, Woodcock J, Midthun K, et al. Developing the nation's biosimilars program. N Engl J Med. 2011;365(5):385–388.
   PubMed Web of Science ®Google Scholar
• Moorkens E, Meuwissen N, Huys I, et al. The market of biopharmaceutical medicines: a snapshot of a diverse industrial landscape. Front Pharmacol. 2017;8:314.
   Google Scholar
• Galbraith D. Biosimilars awaken CROs. BioProcess Int. 2014;12(Suppl 6):s24–s27.
   Google Scholar
• Zhu J. Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv. 2012;30(5):1158–1170.
   PubMed Web of Science ®Google Scholar
• Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004;22(11):1393–1398.
   PubMed Web of Science ®Google Scholar
• Li F, Vijayasankaran N, Shen A, et al. Cell culture processes for monoclonal antibody production. MAbs. 2010;2(5):466–479.
   Google Scholar
• Lalonde ME, Durocher Y. Therapeutic glycoprotein production in mammalian cells. J Biotechnol. 2017;251:128–140.
   PubMed Web of Science ®Google Scholar
• Brown AJ, James DC. Precision control of recombinant gene transcription for CHO cell synthetic biology. Biotechnol Adv. 2016;34(5):492–503.
   PubMed Web of Science ®Google Scholar
• Fischer S, Handrick R, Otte K. The art of CHO cell engineering: a comprehensive retrospect and future perspectives. Biotechnol Adv. 2015;33(8):1878–1896.
   PubMed Web of Science ®Google Scholar
• Hansen HG, Pristovšek N, Kildegaard HF, et al. Improving the secretory capacity of Chinese hamster ovary cells by ectopic expression of effector genes: Lessons learned and future directions. Biotechnol Adv. 2017;35(1):64–76.
   PubMed Web of Science ®Google Scholar
• Wurm FM, Hildinger M, De Jesus M, et al. Fast generation of high expression stable cell lines expressing recombinant proteins under minimal and short-term selective pressure. Patent US20100311116A1. 2010.
   Google Scholar
• Pilbrough W, Munro TP, Gray P. Intraclonal protein expression heterogeneity in recombinant CHO cells. PLOS One. 2009;4(12):e8432.
   PubMed Web of Science ®Google Scholar
• Vcelar S, Melcher M, Auer N, et al. Changes in chromosome counts and patterns in CHO cell lines upon generation of recombinant cell lines and subcloning. Biotechnol J. 2018;13(3):1700495.
   Web of Science ®Google Scholar
• Kwaks TH, Otte AP. Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends Biotechnol. 2006;24(3):137–142.
   PubMed Web of Science ®Google Scholar
• Bailey LA, Hatton D, Field R, et al. Determination of Chinese hamster ovary cell line stability and recombinant antibody expression during long-term culture. Biotechnol Bioeng. 2012;109(8):2093–2103.
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Olivares EC, Hollis RP, et al. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol Cell Biol. 2001;21(12):3926–3934.
   PubMed Web of Science ®Google Scholar
• Gorman C, Bullock C. Site-specific gene targeting for gene expression in eukaryotes. Curr Opin Biotechnol. 2000;11(5):455–460.
   PubMed Web of Science ®Google Scholar
• Baer A, Bode J. Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr Opin Biotechnol. 2001;12(5):473–480.
   PubMed Web of Science ®Google Scholar
• Turan S, Galla M, Ernst E, et al. Recombinase-mediated cassette exchange (RMCE): traditional concepts and current challenges. J Mol Biol. 2011;407(2):193–221.
   PubMed Web of Science ®Google Scholar
• Garrick D, Fiering S, Martin DI, et al. Repeat-induced gene silencing in mammals. Nat Genet. 1998;18(1):56–59.
   PubMed Web of Science ®Google Scholar
• Brown M, Renner G, Field R, et al. Process development for the production of recombinant antibodies using the glutamine synthetase (GS) system. Cytotechnology. 1992;9(1–3):231–236.
   PubMed Web of Science ®Google Scholar
• Fan L, Kadura I, Krebs LE, et al. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells. Biotechnol Bioeng. 2012;109(4):1007–1015.
   PubMed Web of Science ®Google Scholar
• Chusainow J, Yang YS, Yeo JH, et al. A study of monoclonal antibody-producing CHO cell lines: what makes a stable high producer? Biotechnol Bioeng. 2009;102(4):1182–1196.
   PubMed Web of Science ®Google Scholar
• Porter AJ, Racher AJ, Preziosi R, et al. Strategies for selecting recombinant CHO cell lines for cGMP manufacturing: improving the efficiency of cell line generation. Biotechnol Prog. 2010;26(5):1455–1464.
   PubMed Web of Science ®Google Scholar
• Jayapal KP, Wlaschin KF, Hu W, et al. Recombinant protein therapeutics from CHO cells-20 years and counting. Chem Eng Prog. 2007;103(10):40.
   Web of Science ®Google Scholar
• Hou JJC, Hughes BS, Smede M, et al. High-throughput ClonePix FL analysis of mAb-expressing clones using the UCOE expression system. N Biotechnol. 2014;31(3):214–220.
   PubMed Web of Science ®Google Scholar
• Lee JS, Grav LM, Lewis NE, et al. CRISPR/Cas9-mediated genome engineering of CHO cell factories: application and perspectives. Biotechnol J. 2015;10(7):979–994.
   PubMed Web of Science ®Google Scholar
• Stolfa G, Smonskey MT, Boniface R, et al. CHO‐omics review: the impact of current and emerging technologies on Chinese hamster ovary based bioproduction. Biotechnol J. 2018;13(3):1700227.
   PubMed Web of Science ®Google Scholar
• Nash HA. Site-specific recombination: integration, excision, resolution, and inversion of defined DNA segments. Escherichia coli and Salmonella: cellular and Molecular Biology. 1996;2:2363–2376.
   Google Scholar
• Stark WM, Boocock MR, Sherratt DJ. Catalysis by site-specific recombinases. Trends Genet. 1992;8(12):432–439.
   PubMed Web of Science ®Google Scholar
• Hershey AD. The bacteriophage lambda. 792S., 130 Abb., 139 Tab., 12 Taf. Cold Spring Harbor 1971: Cold Spring Harbor Laboratory.
   Google Scholar
• Akopian A, Stark WM. Site-specific DNA recombinases as instruments for genomic surgery. Adv Genet. 2005;55:1–23.
   PubMed Web of Science ®Google Scholar
• Nunes-Düby SE, Kwon HJ, Tirumalai RS, et al. Similarities and differences among 105 members of the Int family of site-specific recombinases. Nucleic Acids Res. 1998;26(2):391–406.
   PubMed Web of Science ®Google Scholar
• Sadowski P. Site-specific recombinases: changing partners and doing the twist. J Bacteriol. 1986;165(2):341–347.
   PubMed Web of Science ®Google Scholar
• Kolb AF. Genome engineering using site-specific recombinases. Cloning Stem Cells. 2002;4(1):65–80.
   PubMedGoogle Scholar
• Sauer B. Site-specific recombination: developments and applications. Curr Opin Biotechnol. 1994;5(5):521–527.
   PubMedGoogle Scholar
• Craig NL. The mechanism of conservative site-specific recombination. Annu Rev Genet. 1988;22(1):77–105.
   PubMedGoogle Scholar
• Olorunniji FJ, Rosser SJ, Stark WM. Site-specific recombinases: molecular machines for the genetic revolution. Biochem J. 2016;473(6):673–684.
   PubMedGoogle Scholar
• Ain QU, Chung JY, Kim YH. Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN. J Control Release. 2015;205:120–127.
   PubMed Web of Science ®Google Scholar
• Cheng JK, Alper HS. The genome editing toolbox: a spectrum of approaches for targeted modification. Curr Opin Biotechnol. 2014;30:87–94.
   PubMed Web of Science ®Google Scholar
• Sun N, Abil Z, Zhao H. Recent advances in targeted genome engineering in mammalian systems. Biotechnol J. 2012;7(9):1074–1087.
   PubMed Web of Science ®Google Scholar
• Smith MC, Brown WR, McEwan AR, et al. Site-specific recombination by φC31 integrase and other large serine recombinases. Biochem Soc Trans. 2010;38:388–394.
   Google Scholar
• Van Duyne GD. A structural view of tyrosine recombinase site-specific recombination. In: Craig, NL, Craigie R, Gellert M, Lambowitz, AM. editors. Mobile DNA II; p. 93–117.
   Google Scholar
• Qiao J, Oumard A, Wegloehner W, et al. Novel tag-and-exchange (RMCE) strategies generate master cell clones with predictable and stable transgene expression properties. J Mol Biol. 2009;390(4):579–594.
   PubMed Web of Science ®Google Scholar
• Turan S, Zehe C, Kuehle J, et al. Recombinase-mediated cassette exchange (RMCE) – a rapidly-expanding toolbox for targeted genomic modifications. Gene. 2013;515(1):1–27.
   PubMed Web of Science ®Google Scholar
• Smith M, Thorpe HM. Diversity in the serine recombinases. Mol Microbiol. 2002;44(2):299–307.
   PubMed Web of Science ®Google Scholar
• Smith AJ, De Sousa MA, Kwabi-Addo B, et al. A site-directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination. Nat Genet. 1995;9(4):376–385.
   PubMed Web of Science ®Google Scholar
• Utomo AR, Nikitin AY, Lee W-H. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat Biotechnol. 1999;17(11):1091–1096.
   PubMed Web of Science ®Google Scholar
• Seibler J, Schübeler D, Fiering S, et al. DNA cassette exchange in ES cells mediated by Flp recombinase: an efficient strategy for repeated modification of tagged loci by marker-free constructs. Biochemistry. 1998;37(18):6229–6234.
   PubMed Web of Science ®Google Scholar
• Kito M, Itami S, Fukano Y, et al. Construction of engineered CHO strains for high-level production of recombinant proteins. Appl Microbiol Biotechnol. 2002;60(4):442–448.
   PubMed Web of Science ®Google Scholar
• Kim MS, Kim WH, Lee GM. Characterization of site-specific recombination mediated by Cre recombinase during the development of erythropoietin producing CHO cell lines [journal article. Biotechnol Bioproc E. 2008;13(4):418–423.
   Web of Science ®Google Scholar
• Holliday R, Ho T. Evidence for gene silencing by endogenous DNA methylation. Proc Natl Acad Sci USA. 1998;95(15):8727–8732.
   PubMed Web of Science ®Google Scholar
• Gupta RS, Siminovitch L. Mutants of CHO cells resistant to the protein synthesis inhibitors, cryptopleurine and tylocrebrine: genetic and biochemical evidence for common site of action of emetine, cryptopleurine, tylocrebine, and tubulosine. Biochemistry. 1977; 16(14):3209–3214.
   PubMed Web of Science ®Google Scholar
• Bech-Hansen NT, Till JE, Ling V. Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity. J Cell Physiol. 1976;88(1):23–31.
   PubMed Web of Science ®Google Scholar
• Mayrhofer P, Kratzer B, Sommeregger W, et al. Accurate comparison of antibody expression levels by reproducible transgene targeting in engineered recombination-competent CHO cells. Appl Microbiol Biotechnol. 2014;98(23):9723–9733.
   PubMed Web of Science ®Google Scholar
• Yujiro K, Yoshinori K, Akira I, et al. An accumulative site‐specific gene integration system using cre recombinase‐mediated cassette exchange. Biotechnol Bioeng. 2010;105(6):1114.
   Web of Science ®Google Scholar
• Hampel S, Chung P, McKellar CE, et al. Drosophila Brainbow: a recombinase-based fluorescence labeling technique to subdivide neural expression patterns [Article. Nat Methods. 2011;8(3):253–259.
   PubMed Web of Science ®Google Scholar
• Hoess RH, Wierzbicki A, Abremski K. The role of the loxP spacer region in P1 site-specific recombination. Nucleic Acids Res. 1986;14(5):2287–2300.
   PubMed Web of Science ®Google Scholar
• Lee G, Saito I. Role of nucleotide sequences of loxP spacer region in Cre-mediated recombination. Gene. 1998;216(1):55–65.
   PubMed Web of Science ®Google Scholar
• Oberdoerffer P, Otipoby KL, Maruyama M, et al. Unidirectional Cre-mediated genetic inversion in mice using the mutant loxP pair lox66/lox71. Nucleic Acids Res. 2003;31(22):e140.
   PubMed Web of Science ®Google Scholar
• Kawabe Y, Makitsubo H, Kameyama Y, et al. Repeated integration of antibody genes into a pre-selected chromosomal locus of CHO cells using an accumulative site-specific gene integration system. Cytotechnology. 2012;64(3):267–279.
   PubMed Web of Science ®Google Scholar
• Yoshinori K, Takuya S, Shuohao H, et al. Targeted transgene insertion into the CHO cell genome using Cre recombinase‐incorporating integrase‐defective retroviral vectors. Biotechnol Bioeng. 2016;113(7):1600–1610.
   PubMed Web of Science ®Google Scholar
• Nern A, Pfeiffer BD, Svoboda K, et al. Multiple new site-specific recombinases for use in manipulating animal genomes. Proc Natl Acad Sci USA. 2011;108(34):14198–14203.
   PubMed Web of Science ®Google Scholar
• Crawford Y, Zhou M, Hu Z, et al. Fast identification of reliable hosts for targeted cell line development from a limited-genome screening using combined φC31 integrase and CRE-Lox technologies. Biotechnol Prog. 2013;29(5):1307–1315.
   PubMed Web of Science ®Google Scholar
• Ou HL, Huang Y, Qu LJ, et al. A phiC31 integrase-mediated integration hotspot in favor of transgene expression exists in the bovine genome . Febs J. 2009;276(1):155–163.
   PubMed Web of Science ®Google Scholar
• Keravala A, Chavez CL, Hu G, et al. Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy. Gene Ther. 2011;18(8):842–848.
   PubMed Web of Science ®Google Scholar
• Haas AK, von Schwerin C, Matscheko D, et al. Fluorescent Citrine-IgG fusion proteins produced in mammalian cells. MAbs. 2010;2(6):648–661.
   PubMed Web of Science ®Google Scholar
• Brezinsky S, Chiang G, Szilvasi A, et al. A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J Immunol Methods. 2003;277(1–2):141–155.
   PubMed Web of Science ®Google Scholar
• Patterson GH, Lippincott-Schwartz J. A photoactivatable GFP for selective photolabeling of proteins and cells. Science. 2002;297(5588):1873–1877.
   PubMed Web of Science ®Google Scholar
• Craggs TD. Green fluorescent protein: structure, folding and chromophore maturation. Chem Soc Rev. 2009;38(10):2865–2875.
   PubMed Web of Science ®Google Scholar
• Baumann M, Gludovacz E, Sealover N, et al. Preselection of recombinant gene integration sites enabling high transcription rates in CHO cells using alternate start codons and recombinase mediated cassette exchange. Biotechnol Bioeng. 2017;114(11):2616–2627.
   PubMed Web of Science ®Google Scholar
• Inniss MC, Bandara K, Jusiak B, et al. A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO cells. Biotechnol Bioeng. 2017;114(8):1837–1846.
   PubMed Web of Science ®Google Scholar
• Zhang L, Inniss MC, Han S, et al. Recombinase-mediated cassette exchange (RMCE) for monoclonal antibody expression in the commercially relevant CHOK1SV cell line. Biotechnol Prog. 2015;31(6):1645–1656.
   PubMed Web of Science ®Google Scholar
• Scarcelli JJ, Shang TQ, Iskra T, et al. Strategic deployment of CHO expression platforms to deliver Pfizer’s monoclonal antibody portfolio. Biotechnol Progress. 2017;33(6):1463–1467.
   PubMed Web of Science ®Google Scholar
• de la C, Edmonds MC, Tellers M, Chan C, et al. Development of transfection and high-producer screening protocols for the CHOK1SV cell system. Mol. Biotechnol. 2006;34(2):179–190.
   PubMed Web of Science ®Google Scholar
• Barnes LM, Bentley CM, Dickson AJ. Advances in animal cell recombinant protein production: GS-NS0 expression system. Cytotechnology. 2000;32(2):109–123.
   PubMed Web of Science ®Google Scholar
• Jusiak B, Jagtap K, Gaidukov L, et al. Comparison of integrases identifies Bxb1-GA mutant as the most efficient site-specific integrase system in mammalian cells. ACS Synth Biol. 2019;8(1):16–24.
   PubMed Web of Science ®Google Scholar
• Gaidukov L, Wroblewska L, Teague B, et al. A multi-landing pad DNA integration platform for mammalian cell engineering. Nucleic Acids Res. 2018;46(8):4072–4086.
   PubMed Web of Science ®Google Scholar
• Stuible M, van Lier F, Croughan MS, et al. Beyond preclinical research: production of CHO-derived biotherapeutics for toxicology and early-phase trials by transient gene expression or stable pools. Curr Opin Chem Eng. 2018;22:145–151.
   Web of Science ®Google Scholar
• Ringrose L, Lounnas V, Ehrlich L, et al. Comparative kinetic analysis of FLP and cre recombinases: mathematical models for DNA binding and recombination. J Mol Biol. 1998;284(2):363–384.
   PubMed Web of Science ®Google Scholar
• Gilbertson L. Cre-lox recombination: creative tools for plant biotechnology. Trends Biotechnol. 2003;21(12):550–555.
   PubMed Web of Science ®Google Scholar
• Wirth D, Gama-Norton L, Riemer P, et al. Road to precision: recombinase-based targeting technologies for genome engineering. Curr Opin Biotechnol. 2007;18(5):411–419.
   PubMed Web of Science ®Google Scholar
• Voziyanova E, Malchin N, Anderson RP, et al. Efficient Flp-Int HK022 dual RMCE in mammalian cells. Nucleic Acids Res. 2013;41(12):e125.
   PubMed Web of Science ®Google Scholar
• Anderson RP, Voziyanova E, Voziyanov Y. Flp and Cre expressed from Flp-2A-Cre and Flp-IRES-Cre transcription units mediate the highest level of dual recombinase-mediated cassette exchange. Nucleic Acids Res. 2012;40(8):e62.
   PubMed Web of Science ®Google Scholar
• Thyagarajan B, Guimaraes M, Groth A, et al. Mammalian genomes contain active recombinase recognition sites. Gene. 2000;244(1–2):47–54.
   PubMed Web of Science ®Google Scholar
• Schmidt-Supprian M, Rajewsky K. Vagaries of conditional gene targeting. Nat Immunol. 2007;8(7):665–668.
   PubMed Web of Science ®Google Scholar
• Coppoolse ER, de Vroomen MJ, Roelofs D, et al. Cre recombinase expression can result in phenotypic aberrations in plants. Plant Mol Biol. 2003;51(2):263–279.
   PubMed Web of Science ®Google Scholar
• Pfeifer A, Brandon EP, Kootstra N, et al. Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc Natl Acad Sci USA. 2001;98(20):11450–11455.
   PubMed Web of Science ®Google Scholar
• Liu H, Zeng F, Zhang M, et al. Emerging landscape of cell penetrating peptide in reprogramming and gene editing. J Control Release. 2016;226:124–137.
   PubMed Web of Science ®Google Scholar
• Kaitsuka T, Tomizawa K. Cell-penetrating peptide as a means of directing the differentiation of induced-pluripotent stem cells. Int J Mol Sci. 2015;16(11):26667–26676.
   PubMed Web of Science ®Google Scholar
• Grdisa M. The delivery of biologically active (therapeutic) peptides and proteins into cells. Curr Med Chem. 2011;18(9):1373–1379.
   PubMed Web of Science ®Google Scholar
• Patsch C, Kesseler D, Edenhofer F. Genetic engineering of mammalian cells by direct delivery of FLP recombinase protein. Methods. 2011;53(4):386–393.
   PubMed Web of Science ®Google Scholar
• Hamaker NK, Lee KH. Site-specific integration ushers in a new era of precise CHO cell line engineering. Curr Opin Chem Eng. 2018;22:152–160.
   PubMed Web of Science ®Google Scholar
• Rose T, Knabe A, Berthold R, et al. A robust RMCE system based on a CHO-DG44 platform enables efficient evaluation of complex biological drug candidates. BMC Proc. 2013;7(Suppl 6). DOI:10.1186/1753-6561-7-S6-P66
   Google Scholar